Home LiteratureArticle Details
PMID: 9039248 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease.

Thorax ·Vol. 52 ·No. 1 ·1997-01-00 ·Pages 67-71

Osman IM, Godden DJ, Friend JA, Legge JS, Douglas JG

Abstract

There is some evidence that quality of life (QOL) in patients with chronic obstructive pulmonary disease (COPD) may predict clinical outcomes and use of resources. This study examined whether QOL scores could prospectively predict re-admission for COPD or death within 12 months of an original admission, and whether QOL scores predicted home nebuliser provision. The study was carried out in all acute medical wards of Aberdeen Royal Infirmary, Woodend and City Hospitals, Aberdeen over 12 months. A total of 377 patients admitted with an exacerbation of COPD were identified in this time, 111 of whom were not included in the study because they refused the interview or died before discharge. The remaining 266 patients completed the St George's Respiratory Questionnaire (SGRQ). Information on spirometric parameters, nebuliser provision at discharge, provision of domiciliary oxygen, and re-admission within 12 months was collected from patient notes. The mean age of the patients was 68 years and 53% were men. The mean (SD) forced expiratory volume in one second (FEV1) was 38.8 (18.0)% predicted and forced vital capacity (FVC) was 58.9 (23.8)% predicted. Higher (worse) scores on the SGRQ were significantly related to re-admission for COPD in the next 12 months (difference = 4.8, 95% CI 1.6 to 8.0). Patients who were re-admitted and died from COPD did not differ in SGRQ scores from those who were re-admitted and survived for more than 12 months. Re-admission was not related to sex, age, or pulmonary function. One hundred and thirty eight patients did not have a home nebuliser before admission. Of these, 14 were provided with a home nebuliser at discharge. Patients provided with nebulisers had significantly worse SGRQ scores and worse FVC. The 41 patients given domiciliary oxygen did not differ in SGRQ or spirometric parameters. Logistic regression analysis of the three SGRQ subscales (Symptom, Impact and Activity), adjusting for lung function, age and sex, showed that all three subscales were significantly related to hospital readmission and that Impact scores were related to nebuliser provision. Women did not differ from men in Symptom scores on the SGRQ but differed markedly on the Activity and Impact scales. It is concluded that poor scores on the SGRQ, a QOL scale which measures patient distress and coping, are associated with re-admission for COPD and use of resources such as nebulisers, independent of physiological measures of disease severity.

MeSH Terms
Adult Age Factors Aged Aged, 80 and over Forced Expiratory Volume Humans Logistic Models Lung Diseases, Obstructive/physiopathology,therapy Middle Aged Nebulizers and Vaporizers Oxygen Inhalation Therapy Patient Readmission Prospective Studies Quality of Life Sex Factors Sickness Impact Profile Vital Capacity
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Osman I M
Thoracic Medicine Unit, Aberdeen Royal Hospitals Trust, UK.
Godden D J
Friend J A
Legge J S
Douglas J G
References (15)
15 references, click to expand
  1. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease.
    Thorax. 1994 May;49(5):468-72 PMID: 8016768
  2. Why quality of life measures should be used in the treatment of patients with respiratory illness.
    Monaldi Arch Chest Dis. 1994 Feb;49(1):79-82 PMID: 8193627
  3. Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease.
    Thorax. 1996 Jan;51(1):39-43 PMID: 8658367
  4. The Sickness Impact Profile: development and final revision of a health status measure.
    Med Care. 1981 Aug;19(8):787-805 PMID: 7278416
  5. Symptoms and experiences in chronic bronchitis and emphysema.
    Chest. 1983 May;83(5):755-61 PMID: 6839816
  6. Quality of life in patients with chronic airflow limitation.
    Br J Dis Chest. 1987 Jan;81(1):45-54 PMID: 3663490
  7. A measure of quality of life for clinical trials in chronic lung disease.
    Thorax. 1987 Oct;42(10):773-8 PMID: 3321537
  8. Measures of symptoms and life quality to predict emergent use of institutional health care resources in chronic obstructive airways disease.
    Heart Lung. 1988 Nov;17(6 Pt 1):689-97 PMID: 3192415
  9. Experimental evaluation of rehabilitation in chronic obstructive pulmonary disease: short-term effects on exercise endurance and health status.
    Health Psychol. 1990;9(3):237-52 PMID: 2187694
  10. Quality of life in elderly patients with chronic nonspecific lung disease seen in family practice.
    Chest. 1990 Oct;98(4):894-9 PMID: 2209145
  11. Psychological outcomes of a pulmonary rehabilitation program.
    Chest. 1991 Sep;100(3):613-7 PMID: 1889242
  12. The St George's Respiratory Questionnaire.
    Respir Med. 1991 Sep;85 Suppl B:25-31; discussion 33-7 PMID: 1759018
  13. Using multidimensional health measures in older persons to identify risk of hospitalization and skilled nursing placement.
    Qual Life Res. 1993 Aug;2(4):253-61 PMID: 8220360
  14. Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home.
    Eur Respir J. 1994 Feb;7(2):269-73 PMID: 8162979
  15. Randomised controlled trial of respiratory rehabilitation.
    Lancet. 1994 Nov 19;344(8934):1394-7 PMID: 7968075
Article Info
Journal
Thorax
Abbr.
Thorax
ISSN
0040-6376
Published
1997-01-00
Pages
67-71
Language
English
Region
England
NLM ID
0417353
PMCID
PMC1758400
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com